Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Crispr Therapeutics Ag (CRSP)  
$51.17 2.38 (4.44%) as of 4:30 Fri 5/10


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 70,650,000
Market Cap: 3.62(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $38.62 - $89.12
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   CRISPR Therapeutics is a gene editing company focused on the development of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) based therapeutics. CRISPR/Cas9 is a technology for gene editing, the process of altering specific sequences of genomic DNA. Co. is developing several gene-edited allogeneic cell therapy programs. Co.'s main product candidate, CTX001, is an investigational ex vivo CRISPR gene-edited therapy that is being evaluated for patients suffering from transfusion-dependent beta thalassemia or severe sickle cell disease in which a patient's hematopoietic stem cells are engineered to produce fetal hemoglobin in red blood cells.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 89,721 159,721 184,721 409,721
Total Sell Value $6,558,882 $10,834,513 $12,456,407 $25,314,056
Total People Sold 3 3 3 3
Total Sell Transactions 10 12 13 22
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 483
  Page 5 of 20  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Kulkarni Samarth Chief Executive Officer   •       •      –    2021-08-04 4 OE $12.57 $18,855 D/D 1,500 189,219     -
   Bolzon Bradley J Phd Director   –       •      –    2021-07-19 4 AS $125.67 $1,264,348 I/I (10,000) 148,831 -36%     
   Novak Rodger President   •       •      –    2021-06-30 4 AS $165.00 $4,125,000 D/D (25,000) 573,007 -44%     
   Bolzon Bradley J Phd Director   –       •      –    2021-06-29 4 AS $145.92 $7,106,341 D/D (47,536) 0 -38%     
   Bolzon Bradley J Phd Director   –       •      –    2021-06-28 4 A $0.00 $0 D/D 47,536 47,536     -
   Bolzon Bradley J Phd Director   –       •      –    2021-06-28 4 AS $0.00 $0 I/I (1,285,027) 0 -36%     
   Bolzon Bradley J Phd Director   –       •      –    2021-06-28 4 A $0.00 $0 I/I 248,625 6,018     -
   Bolzon Bradley J Phd Director   –       •      –    2021-06-28 4 AS $150.65 $1,524,799 I/I (10,000) 158,831 -36%     
   Bolzon Bradley J Phd Director   –       •      –    2021-06-28 4 AS $150.65 $3,106,783 D/D (20,375) 0 -36%     
   Novak Rodger President   •       •      –    2021-06-28 4 AS $156.55 $3,913,750 D/D (25,000) 598,007 -36%     
   Novak Rodger President   •       •      –    2021-06-21 4 AS $125.58 $3,215,458 D/D (25,000) 623,007 -28%     
   Kulkarni Samarth Chief Executive Officer   •       •      –    2021-06-15 4 AS $125.39 $3,792,804 D/D (30,000) 187,719 -21%     
   Kulkarni Samarth Chief Executive Officer   •       •      –    2021-06-15 4 OE $12.57 $377,100 D/D 30,000 217,719     -
   Bolzon Bradley J Phd Director   –       •      –    2021-06-11 4 AS $125.62 $1,266,118 D/D (10,000) 20,375 -21%     
   Kulkarni Samarth Chief Executive Officer   •       •      –    2021-06-01 4 D $115.80 $90,208 D/D (779) 187,719     -
   Klein Lawrence Otto CBO & COO   •       –      –    2021-03-23 4 AS $126.97 $12,805,240 D/D (100,000) 1,050 -3%     
   Klein Lawrence Otto CBO & COO   •       –      –    2021-03-23 4 OE $14.43 $3,170,000 D/D 88,000 101,050     -
   Bolzon Bradley J Phd Director   –       •      –    2021-03-22 4 AS $129.36 $4,020,667 D/D (30,374) 30,375 -9%     
   Klein Lawrence Otto CBO & COO   •       –      –    2021-03-10 4 D $124.15 $265,805 D/D (2,141) 13,050     -
   Klein Lawrence Otto CBO & COO   •       –      –    2021-03-10 4 OE $0.00 $0 D/D 4,583 15,191     -
   Kasinger James R. General Counsel and Secretary   •       –      –    2021-03-10 4 D $124.15 $167,975 D/D (1,353) 23,911     -
   Kasinger James R. General Counsel and Secretary   •       –      –    2021-03-10 4 OE $0.00 $0 D/D 2,833 25,264     -
   Ho Tony W Executive VP, Head of R&D   •       –      –    2021-03-10 4 D $124.15 $265,805 D/D (2,141) 38,304     -
   Ho Tony W Executive VP, Head of R&D   •       –      –    2021-03-10 4 OE $0.00 $0 D/D 4,583 40,445     -
   Kulkarni Samarth Chief Executive Officer   •       •      –    2021-03-10 4 D $124.15 $686,053 D/D (5,526) 188,498     -
  483 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 5 of 20
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us